-Signed Global Contract with Barco NV-
LONDON, July 19 /PRNewswire-FirstCall/ -- MGT Capital Investments, Inc. (AMEX:MGT), an investment company focused on the Healthcare Information Technology ("HCIT") sector, announced today recent development surrounding the listing of its subsidiary, Medicsight PLC (AIM: MDST), on the AIM Market of the London Stock Exchange.
Tim Paterson-Brown, Chairman and CEO, stated, "We are pleased with the progress that Medicsight has made with expanding its corporate partnerships, obtaining regulatory approvals and showcasing its CAD software at scientific conferences. The Company's agreements to date enable Medicsight and its partners to accelerate penetration into the growing CAD market. The recent addition of Barco brings the total installed base of Medicsight partners to over 7,500 CT workstations and licenses." Commercial Partnerships Medicsight distributes its products through partnerships with some of the leading 3D visualisation equipment manufacturers. Medicsight has recently reinforced its global distribution capability and relationships with three key partners: Vital Images, Inc., Viatronix, Inc., and TeraRecon, Inc. The Viatronix global contracts have been re-signed to improve commercial terms and practical business arrangements.
Medicsight has signed a global contract with Barco N.V., a leading provider of enterprise-wide 3D advanced visualization solutions, which will enable Medicsight's ColonCAD(TM) image analysis software tools to be distributed with Barco's 3D visualization products and through the Picture Archiving and Communication Systems (PACS) offered by Barco's partners.
Regulatory Approvals On June 4, 2007, Medicsight CE marked MedicRead Colon 1.0 and ColonCAD(TM) API 3.2, indicating conformity with the essential safety requirements set out in the European Medical Device Directives.
On July 5, 2007, Medicsight was granted medical device licences from the Therapeutic Products Directorate of Health Canada to begin marketing and selling Medicsight MedicRead Colon 1.0 in Canada.
Conference participation Medicsight showcased its CAD software at the following radiology conferences this year: -- March 9-13, 2007, Professor Steve Halligan of University College
Hospital, London, and Dr. David Burling of St. Mark's Hospital, London,
gave presentations on Medicsight CAD technology at the European
Congress of Radiology, Vienna -- April 13-15, 2007, Medicsight and Toshiba co-sponsored the first CT
Colonography training workshop at the Japan Radiological Society in
Yokohama, Japan -- June 12-15, 2007, Professor Steve Halligan, Dr Stuart Taylor of
University College Hospital, London and Dr. David Burling gave
presentations on Medicsight CAD technology at the European Society of
Gastrointestinal and Abdominal Radiology, Lisbon About MGT Capital Investments, Inc. MGT Capital Investments is an investment company with two direct subsidiaries that focus solely on the dynamic and consolidating HCIT sector. The first subsidiary, Medicsight PLC, is a leading developer of computer-aided detection (CAD) and computer assisted reader (CAR) software solutions that are tested using one of the world's largest databases of verified CT scan data. Medicsight's CAD and CAR products help clinicians identify, measure, and analyze suspicious pathology, such as colorectal polyps and lung lesions. MGT Capital Investments has invested in and controls a second subsidiary, Medicexchange PLC, which operates http://www.medicexchange.com/, an online multi- vendor sales channel for diagnostic, treatment and surgery planning solutions for cardiac, thoracic, breast imaging, orthopedic, and gastro intestinal imaging. Medicexchange.com provides these solutions in a low-cost, on-demand and downloadable format, enhancing access to information and products for medical imaging professionals. Additional information can be found at http://www.mgtci.com/.
All forward-looking statements are made pursuant to the 'safe harbor' provisions of the Private Securities Litigation Reform Act of 1995. Forward- looking statements are based on current management expectations that involve risks and uncertainties that may result in such expectations not being realized. Potential risks and uncertainties include, but are not limited to, the risks described in company filings with the Securities and Exchange Commission.
Company contacts:
MGT Capital Investments, Inc. Alex van Klaveren
1410 Broadway
22nd Floor
New York, NY 10018
+1 646-257-2644
For more information:
Investors:
Stephanie Carrington / Zack Kubow
+1 646-536-7017 / 7020
DATASOURCE: MGT Capital Investments, Inc.
CONTACT: Alex van Klaveren of MGT Capital Investments, Inc., +1-646-257-2644, ; or Investors, Stephanie Carrington, +1-646-536-7017, , or Zack Kubow, +1-646-536-7020, , both of The Ruth Group for MGT Capital Investments, Inc.
Web site: http://www.mgtci.com/
|